Carregant...
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study
OBJECTIVES: Report long-term safety and effectiveness of natalizumab over 240 weeks in the prospective, observational, open-label Safety of TYSABRI Re-dosing and Treatment (STRATA) Study. METHODS: Patients (N = 1,094) previously enrolled in natalizumab multiple sclerosis clinical trials received nat...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4114173/ https://ncbi.nlm.nih.gov/pubmed/24898925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000541 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|